Nervous System News and Research

Latest Nervous System News and Research

UCSF resident to receive 2012 William P. Van Wagenen Fellowship

The William P. Van Wagenen Fellowship Selection Committee has announced Matthew Christopher Tate, MD, as the recipient of the 2012 William P. Van Wagenen Fellowship. Dr. Tate, a resident in neurological surgery at University of California in San Francisco, will commence the fellowship on July 1, 2012.

7 Dec 2011

Scientists understand how nervous system becomes wired during early development

Thanks to a new study of the retina, scientists at UC Santa Barbara have developed a greater understanding of how the nervous system becomes wired during early development.

7 Dec 2011

Positive final results from BioLineRx BL-1021 Phase Ia study for neuropathic pain

BioLineRx announced today the final results of the Phase Ia study of BL-1021, an orally available small molecule for neuropathic pain.

6 Dec 2011

QAI announces availability of Virtual Human Body App

QA International (QAI) announced today its Virtual Human Body App for iPad is now available from the App Store. People of all ages will enjoy fingertip navigation through the 10 systems and structures of the human body, with lifelike imagery.

6 Dec 2011

WSU study to improve diagnosis of fetal alcohol spectrum disorders

Fetal alcohol spectrum disorders (FASDs) are one of the most common causes of birth defects worldwide and are particularly prevalent in some South African communities where heavy drinking during pregnancy is a major public health issue, particularly in the wine-growing areas of the Western Cape.

6 Dec 2011

Researchers identify brain area that controls voluntary movement after damage

Researchers have identified the area of the brain that controls our ability to correct our movement after we've been hit or bumped -- a finding that may have implications for understanding why subjects with stroke often have severe difficulties moving.

6 Dec 2011

Study looks at how severely low birth weight impacts attention and memory during adulthood

Babies born at a very low birth weight are more likely to have memory and attention problems when they become adults than babies born at a low to normal weight, according to a study published in the December 6, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

6 Dec 2011

Global problem of fatal snakebites and promising solutions highlighted at ASTMH meeting

Fatal snakebites are a bigger-than-acknowledged global health problem that has been vastly under-reported, according to research presented today at the American Society of Tropical Medicine and Hygiene's (ASTMH) annual meeting.

6 Dec 2011

Study reveals mechanism of action of laquinimod in patients with RRMS

Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).

6 Dec 2011

EnVivo presents positive EVP-6124 Phase 2b trial data on schizophrenia at 50th ACNP meeting

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.

5 Dec 2011

Fatal snakebites emerging global threat

5 Dec 2011

Targacept commences two clinical studies of TC-5619 for schizophrenia and ADHD

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.

5 Dec 2011

Subconscious nervous impulses may be prognostic markers for weight-loss outcome

A recent study of obese volunteers participating in a 12-week dietary weight-loss program found that successful weight losers had significantly higher resting nerve activity compared to weight-loss resistant individuals.

5 Dec 2011

Post-baseline vision data from Lundbeck's Sabril patient registry presented at AES meeting

Post-baseline vision data from Lundbeck's Sabril patient registry is available for the first time today as a late-breaking poster presentation at the annual meeting of the American Epilepsy Society.

5 Dec 2011

Researchers identify critical steps leading to myelin destruction in neuromyelitis optica

Mayo Clinic researchers have identified critical steps leading to myelin destruction in neuromyelitis optica (NMO), a debilitating neurological disease that is commonly misdiagnosed as multiple sclerosis (MS). The findings could lead to better care for the thousands of patients around the world with NMO. The paper was published in the journal, Proceedings of the National Academy of Sciences, USA.

3 Dec 2011

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Ceregene, Inc. reported today that it has completed enrollment in its Phase 2b trial of CERE-120, a gene therapy product expressing the neurturin (NRTN) gene for the treatment of Parkinson's disease.

1 Dec 2011

New marker may provide more accurate diagnosis of Alzheimer's, FTLD

New research finds a marker used to detect plaque in the brain may help doctors make a more accurate diagnosis between two common types of dementia - Alzheimer's disease and frontotemporal lobar degeneration.

1 Dec 2011

First study to investigate risk factors for CCSVI in patients without neurological disease

The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis.

1 Dec 2011